Notícias e Atividades da Avadel Pharmaceuticals

Avadel Pharmaceuticals é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

Avadel Pharmaceuticals é uma empresa listada sob o símbolo AVDL (US).

Veja o organograma con seus 19 executivos principais

Biografias mais buscadas da Avadel Pharmaceuticals

• Gregory Divis, Chief Executive Officer and Director
• Mark McCamish, Director
• Peter Thornton, Director

Recentes movimentos de executivos em Avadel Pharmaceuticals

• Kevin Springman, ingressou na Companhia como Vice President of Sales  (Notícia publicada em 26 de fevereiro de 2025).
• Sev Melkonian, ingressou na Companhia como Vice President of Patient Services, Distribution and Reimbursement  (Notícia publicada em 24 de janeiro de 2025).
• Richard Kim, Chief Commercial Officer, deixará a Companhia em 31 de dez. de 2024  (Notícia publicada em 4 de dezembro de 2024).

Criar um alerta
para seguir os movimentos de executivos da Avadel Pharmaceuticals.

Avadel Pharmaceuticals possui 1.830 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Chimerix and Chimerix have merged  (publicado em 22 de abril de 2025)..
• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Seth Harrison - Chairman and Director da Braeburn Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Avadel Pharmaceuticals

• Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9 | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9 | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals Provides Corporate Update | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals Provides Corporate Update | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2022 Young Investigators Research Forum | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2022 Young Investigators Research Forum | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals to Present at the Jefferies Healthcare Conference | Avadel Pharmaceuticals PLC
• Avadel Pharmaceuticals to Present at the Jefferies Healthcare Conference | Avadel Pharmaceuticals PLC
• View more press releases Close

Redes sociais sobre Avadel Pharmaceuticals

• Avadel Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• Avadel Pharmaceuticals na LinkedIn, Twitter e YouTube